LEVELJUMP HEALTHCARE CORP (JUMP.CA) Fundamental Analysis & Valuation

TSX-V:JUMPCA52731E1060

Current stock price

0.065 CAD
+0.01 (+18.18%)
Last:

This JUMP.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. JUMP.CA Profitability Analysis

1.1 Basic Checks

  • JUMP had positive earnings in the past year.
  • In the past year JUMP had a positive cash flow from operations.
  • In multiple years JUMP reported negative net income over the last 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: JUMP reported negative operating cash flow in multiple years.
JUMP.CA Yearly Net Income VS EBIT VS OCF VS FCFJUMP.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -2M -4M -6M -8M -10M

1.2 Ratios

Industry RankSector Rank
ROA 9.12%
ROE 31.37%
ROIC 2.59%
ROA(3y)-1.44%
ROA(5y)-129.29%
ROE(3y)-7.82%
ROE(5y)-734.24%
ROIC(3y)N/A
ROIC(5y)N/A
JUMP.CA Yearly ROA, ROE, ROICJUMP.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K

1.3 Margins

  • JUMP's Profit Margin has improved in the last couple of years.
  • In the last couple of years the Gross Margin of JUMP has remained more or less at the same level.
Industry RankSector Rank
OM 3.14%
PM (TTM) 10.53%
GM 20.47%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5Y27.11%
GM growth 3Y-3.63%
GM growth 5Y-1.37%
JUMP.CA Yearly Profit, Operating, Gross MarginsJUMP.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -50 -100 -150 -200

1

2. JUMP.CA Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), JUMP is destroying value.
  • The number of shares outstanding for JUMP remains at a similar level compared to 1 year ago.
  • JUMP has more shares outstanding than it did 5 years ago.
  • JUMP has a better debt/assets ratio than last year.
JUMP.CA Yearly Shares OutstandingJUMP.CA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
JUMP.CA Yearly Total Debt VS Total AssetsJUMP.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

2.2 Solvency

  • Based on the Altman-Z score of 0.06, we must say that JUMP is in the distress zone and has some risk of bankruptcy.
  • The Debt to FCF ratio of JUMP is 9.88, which is on the high side as it means it would take JUMP, 9.88 years of fcf income to pay off all of its debts.
  • JUMP has a Debt/Equity ratio of 1.61. This is a high value indicating a heavy dependency on external financing.
Industry RankSector Rank
Debt/Equity 1.61
Debt/FCF 9.88
Altman-Z 0.06
ROIC/WACC0.47
WACC5.56%
JUMP.CA Yearly LT Debt VS Equity VS FCFJUMP.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 2M -2M 4M 6M 8M 10M

2.3 Liquidity

  • A Current Ratio of 0.56 indicates that JUMP may have some problems paying its short term obligations.
  • A Quick Ratio of 0.56 indicates that JUMP may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.56
Quick Ratio 0.56
JUMP.CA Yearly Current Assets VS Current LiabilitesJUMP.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2M 4M 6M

5

3. JUMP.CA Growth Analysis

3.1 Past

  • JUMP shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 394.34%, which is quite impressive.
  • Measured over the past years, JUMP shows a very strong growth in Earnings Per Share. The EPS has been growing by 21.22% on average per year.
  • Looking at the last year, JUMP shows a quite strong growth in Revenue. The Revenue has grown by 14.67% in the last year.
  • The Revenue has been growing by 26.97% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)394.34%
EPS 3YN/A
EPS 5Y21.22%
EPS Q2Q%-200%
Revenue 1Y (TTM)14.67%
Revenue growth 3Y38.18%
Revenue growth 5Y26.97%
Sales Q2Q%8.7%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
JUMP.CA Yearly Revenue VS EstimatesJUMP.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 5M 10M 15M

2

4. JUMP.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 3.25, the valuation of JUMP can be described as very cheap.
  • Compared to an average S&P500 Price/Earnings ratio of 27.53, JUMP is valued rather cheaply.
Industry RankSector Rank
PE 3.25
Fwd PE N/A
JUMP.CA Price Earnings VS Forward Price EarningsJUMP.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 5.28
EV/EBITDA 11.02
JUMP.CA Per share dataJUMP.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 0.1 0.15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.15
EPS Next 2YN/A
EPS Next 3YN/A

0

5. JUMP.CA Dividend Analysis

5.1 Amount

  • No dividends for JUMP!.
Industry RankSector Rank
Dividend Yield 0%

JUMP.CA Fundamentals: All Metrics, Ratios and Statistics

LEVELJUMP HEALTHCARE CORP

TSX-V:JUMP (4/15/2026, 7:00:00 PM)

0.065

+0.01 (+18.18%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)11-10
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners12.27%
Ins Owner ChangeN/A
Market Cap6.27M
Revenue(TTM)18.91M
Net Income(TTM)1.99M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 3.25
Fwd PE N/A
P/S 0.33
P/FCF 5.28
P/OCF 3.33
P/B 0.99
P/tB N/A
EV/EBITDA 11.02
EPS(TTM)0.02
EY30.77%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.01
FCFY18.94%
OCF(TTM)0.02
OCFY29.99%
SpS0.2
BVpS0.07
TBVpS-0.04
PEG (NY)N/A
PEG (5Y)0.15
Graham Number0.172081 (164.74%)
Profitability
Industry RankSector Rank
ROA 9.12%
ROE 31.37%
ROCE 3.74%
ROIC 2.59%
ROICexc 2.6%
ROICexgc 6.56%
OM 3.14%
PM (TTM) 10.53%
GM 20.47%
FCFM 6.28%
ROA(3y)-1.44%
ROA(5y)-129.29%
ROE(3y)-7.82%
ROE(5y)-734.24%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5Y27.11%
GM growth 3Y-3.63%
GM growth 5Y-1.37%
F-Score6
Asset Turnover0.87
Health
Industry RankSector Rank
Debt/Equity 1.61
Debt/FCF 9.88
Debt/EBITDA 6.52
Cap/Depr 71.49%
Cap/Sales 3.67%
Interest Coverage 250
Cash Conversion 120.23%
Profit Quality 59.64%
Current Ratio 0.56
Quick Ratio 0.56
Altman-Z 0.06
F-Score6
WACC5.56%
ROIC/WACC0.47
Cap/Depr(3y)283.26%
Cap/Depr(5y)N/A
Cap/Sales(3y)10.41%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)394.34%
EPS 3YN/A
EPS 5Y21.22%
EPS Q2Q%-200%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)14.67%
Revenue growth 3Y38.18%
Revenue growth 5Y26.97%
Sales Q2Q%8.7%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y459.89%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y213.05%
FCF growth 3YN/A
FCF growth 5Y22.45%
OCF growth 1Y216.44%
OCF growth 3YN/A
OCF growth 5Y47.25%

LEVELJUMP HEALTHCARE CORP / JUMP.CA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for LEVELJUMP HEALTHCARE CORP?

ChartMill assigns a fundamental rating of 2 / 10 to JUMP.CA.


Can you provide the valuation status for LEVELJUMP HEALTHCARE CORP?

ChartMill assigns a valuation rating of 2 / 10 to LEVELJUMP HEALTHCARE CORP (JUMP.CA). This can be considered as Overvalued.


What is the profitability of JUMP stock?

LEVELJUMP HEALTHCARE CORP (JUMP.CA) has a profitability rating of 2 / 10.


How financially healthy is LEVELJUMP HEALTHCARE CORP?

The financial health rating of LEVELJUMP HEALTHCARE CORP (JUMP.CA) is 1 / 10.